Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113712 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Shuhui Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Provinc…. Hauptthemen laut MEDLINE: Matrix Attachment Region Binding Proteins, Hepatitis, Autoimmune, Hepatocytes, Immunity, Innate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Investigating the function of SATB1 in hepatocytes is essential for developing therapeutic strategies for autoimmune hepatitis (AIH). Although SATB1 has been extensively studied in immune cells, its specific activity in hepatocytes within the context of AIH remains unclear. METHODS: SATB1 expression in AIH hepatocytes was assessed by qRT-PCR, Western blotting, flow cytometry, and immunohistochemistry. In vivo modulation used RNA interference viruses and overexpression plasmids. SATB1's proinflammatory effects were analyzed with protein microarray, immunohistochemistry, and flow cytometry. Chemotactic effects on RAW264.7 macrophages were tested in vitro, with mechanisms explored by dual-luciferase assays and CUT&RUN qPCR. Liver injury was evaluated by histopathology and serum biochemistry. RESULTS: SATB1 was significantly upregulated in hepatocytes of AIH patients and models, showing a stronger increase in hepatocytes than in CD45+ cells, and positively correlated with liver injury severity. In vivo RNAi-mediated SATB1 inhibition reduced liver inflammation, while SATB1 overexpression aggravated AIH progression. Both interference and overexpression experiments confirmed that SATB1 promotes liver injury by facilitating the infiltration of proinflammatory (Ly6Chigh) macrophage. In vitro, supernatant from SATB1-overexpressing hepatocytes enriched chemokine signaling pathways, leading to increased CCL2 expression and release, which attracted macrophages and drove their proinflammatory polarization. Mechanistically, SATB1 promoted CCL2 transcription by binding to its DNA and recruiting p300/CBP. CONCLUSIONS: This study reveals that SATB1 is upregulated in hepatocytes in AIH. Elevated SATB1 levels in liver cells contribute to autoimmune hepatitis by increasing CCL2 expression, promoting the recruitment of inflammatory monocyte-derived macrophage, and reshaping the composition of the liver immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
- Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
- Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. Electronic address: 469778613@qq.com.
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. Electronic address: fliumei@126.com.
Förderung
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Wang, S., Huang, Z., Nie, S., Chen, Y., Lei, Y., Tu, W., Luo, M., Zhang, Z. G., Tian, D. A., Gong, J., & Liu, M. (2025). Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113712
Vancouver
Wang S, Huang Z, Nie S, Chen Y, Lei Y, Tu W, et al. Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113712
BibTeX
@article{Wang2025,
author = {Wang, Shuhui and Huang, Zheng and Nie, Shangshu and Chen, Yu and Lei, Yu and Tu, Wei and Luo, Min and Zhang, Zhen-Gang and Tian, De-An and Gong, Jin and Liu, Mei},
title = {Unveiling the interplay between hepatocyte SATB1 and innate immunity in autoimmune hepatitis},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113712}
}
EUVIMED